Detail View

GFRAL antagonistic antibodies and uses thereof
Citations

WEB OF SCIENCE

Citations

SCOPUS

Metadata Downloads

DC Field Value Language
dc.contributor.author 정종원 -
dc.contributor.author 이범용 -
dc.contributor.author 신지원 -
dc.contributor.author 박준국 -
dc.contributor.author 예경무 -
dc.date.accessioned 2025-11-13T16:10:11Z -
dc.date.available 2025-11-13T16:10:11Z -
dc.identifier.uri https://scholar.dgist.ac.kr/handle/20.500.11750/59163 -
dc.description.abstract The present invention relates to GFRAL antagonist antibodies and uses thereof, and more specifically, to anti-GFRAL antibodies comprising heavy chain CDR and light chain CDR of specific sequences, and antigen-binding fragments thereof. Anti-GFRAL antibodies are expected to be useful in the alleviation or treatment of cancer-related anorexia-cachexia syndrome, as well as adverse reactions caused by chemotherapeutics. -
dc.title GFRAL antagonistic antibodies and uses thereof -
dc.title.alternative GFRAL-ANTAGONISTIC ANTIBODY AND USE THEREOF -
dc.type Patent -
dc.publisher.country CC -
dc.identifier.patentApplicationNumber 202180040478.5 -
dc.date.application 2021-06-02 -
dc.identifier.patentRegistrationNumber 115698073 -
dc.date.registration 2023-02-03 -
dc.contributor.assignee DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY -
dc.type.iprs 특허 -
Show Simple Item Record

File Downloads

  • There are no files associated with this item.

공유

qrcode
공유하기

Related Researcher

예경무
Yea, Kyungmoo예경무

Department of New Biology

read more

Total Views & Downloads